INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 426m ago
HOUSE PTR26m ago
SEC 13F26m ago
ROBINHOOD CHAIN25m ago
Public company

INSMINSMED Inc

CIK 0001104506

EDGAR filingsOpen in network
Disclosed transactions53
Buys / sells0 / 33
Max Insider Score39
Connections11with evidence

INSM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KU
Koppikar UtpalDirector
INSMINSMED Inc
Grant or award
A—
6,139 sh
Oct 19, 2026Oct 20, 2026
traded Oct 19, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Koppikar UtpalDirector · Oct 20, 2026
  • ← Insider ofevidence
    Hudson PaulDirector · Oct 20, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA RR 2026 second quarter · Trade · Aug 26, 2026
9
HP
Hudson PaulDirector
INSMINSMED Inc
Grant or award
A
—
6,139 sh
Oct 19, 2026
Oct 20, 2026
traded Oct 19, 2026
+1d
SEC FORM 4

Evidence

4
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
18.3K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

15
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$2.37M
18.3K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

11
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$1.13M
8,895 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

0
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$230K
8,895 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

0
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
8,895 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$346K
18.3K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC FORM 4

Evidence

25
Josh GottheimerDJoint
INSMINSMED Inc
Partial sale
SELL$1,001 – $15KJun 10, 2026Jul 7, 2026
traded Jun 10, 2026
+27dHOUSE PTR

Evidence

9
BS
Butera SamueleSVP, GM, Global Respiratory
INSMINSMED Inc
Grant or award
A—
7,342 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

6
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$173K
1,806 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
BS
Butera SamueleSVP, GM, Global Respiratory
INSMINSMED Inc
Grant or award
A—
12.6K sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

26
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$221K
2,159 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

24
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$477K
4,109 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$96K
5,649 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC FORM 4

Evidence

4
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
5,649 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC FORM 4

Evidence

6
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$390K
14.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC FORM 4

Evidence

15
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$2.96M
19.6K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC FORM 4

Evidence

4
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
14.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC FORM 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$132K
869 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC FORM 4

Evidence

22
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$100K
640 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$351K
1,887 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC FORM 4

Evidence

22
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$124K
709 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC FORM 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$830K
4,783 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$493K
2,830 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$167K
957 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

12
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$280K
1,615 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

22
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$183K
1,053 sh
Jan 8, 2026Jan 8, 2026
traded Jan 8, 2026
+0dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$252K
1,434 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC FORM 4

Evidence

2
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$227K
8,570 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$289K
1,660 sh
Jan 8, 2026Jan 8, 2026
traded Jan 8, 2026
+0dSEC FORM 4

Evidence

22
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale
SELL$242K
1,396 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

0
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
8,570 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$566K
3,251 sh
Jan 8, 2026Jan 8, 2026
traded Jan 8, 2026
+0dSEC FORM 4

Evidence

39
AM
Anderson Elizabeth MDirector
INSMINSMED Inc
Open-market sale
SELL$1.02M
5,000 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

28
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$2.31M
12.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

28
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$2.02M
10.6K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

21
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$556K
2,913 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

0
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
12.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

7
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
18.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$221K
12.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

9
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$346K
18.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

24
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$1.03M
5,467 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

0
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
27.1K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$676K
3,636 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$600K
3,243 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$742K
4,032 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

13
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$644K
27.1K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

13
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$243K
1,342 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$294K
1,572 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$263K
1,400 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

23
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$1.39M
7,619 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$783K
4,286 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Holdsevidence
    Duquesne Family Office LLC2.9% of reported portfolio · Aug 14, 2026
  • ← Disclosed trade inevidence
    Josh GottheimerSale disclosed 2026-07-07 · Jul 7, 2026
  • ← Insider ofevidence
    Butera SamueleSVP, GM, Global Respiratory · Jun 24, 2026
  • ← Insider ofevidence
    Anderson Elizabeth MDirector · Nov 26, 2025
  • ← Insider ofevidence
    Flammer Martina M.D.Chief Medical Officer · Nov 13, 2025
  • ← Insider ofevidence
    Smith Michael AlexanderChief Legal Officer · Nov 5, 2025

    • Lobbying

    $40K reported · de-duplicated
    2026 Q2 $30K via firms2026 Q1 $10K via firms
    • JEFFREY J. KIMBELL & ASSOCIATES, INC.$10K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • LMH STRATEGIC SOLUTIONS$20K2026 Q2 · posted Aug 26, 2026 · Trade
    • JEFFREY J. KIMBELL & ASSOCIATES, INC.$10K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • LMH STRATEGIC SOLUTIONS—2026 Q2 · posted Aug 26, 2026 · Trade

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.